Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome

Biomed Pharmacother. 1989;43(1):19-23. doi: 10.1016/0753-3322(89)90186-8.

Abstract

Nicotine was found to markedly potentiate haloperidol-induced hypokinesia in rats. Nicotine alone was without effect. Subsequently, concurrent administration of 2 mg nicotine gum to 10 Tourette syndrome patients being treated with haloperidol produced a substantial decrease in tics and improvement of concentration and attention span. Nicotine gum alone was without effect. While 80% of children showed improvement with nicotine gum, 70% completely discontinued the gum because of side-effects, primarily involving nausea and bitter taste. Nicotine may prove useful for treating other neuroleptic responsive disorders, such as schizophrenia and Huntington's disease.

MeSH terms

  • Adolescent
  • Animals
  • Behavior, Animal / drug effects
  • Catalepsy / chemically induced
  • Chewing Gum
  • Child
  • Child, Preschool
  • Drug Interactions
  • Female
  • Haloperidol / pharmacology*
  • Haloperidol / therapeutic use
  • Humans
  • Male
  • Nicotine / administration & dosage
  • Nicotine / pharmacology*
  • Nicotine / therapeutic use
  • Rats
  • Rats, Inbred Strains
  • Tic Disorders / drug therapy
  • Tourette Syndrome / drug therapy*
  • Tourette Syndrome / psychology

Substances

  • Chewing Gum
  • Nicotine
  • Haloperidol